| EPA0089 | Support vector machine classification modeling identifies composite biomarkers predictive of non-AIDS events in people with HIV on suppressive anti-retroviral therapy | E-poster | HIV-associated viruses, co-infections and co-morbidities |
| EPA0090 | Impact of HCV clearance on metabolism biomarkers in people living with HIV | E-poster | HIV-associated viruses, co-infections and co-morbidities |
| EPA0091 | Faster disease progression and increased viral replication among HIV-TB co-infected individuals via Mycobacterim tuberculosis mediated modulation of host intrinsic anti-viral factors | E-poster | HIV-associated viruses, co-infections and co-morbidities |
| EPA0092 | In vitro modelling to monitor pathogenic implications of viral co-infections | E-poster | HIV-associated viruses, co-infections and co-morbidities |
| EPA0093 | HIV infection enhances EBV replication and EBV-associated tumorigenesis in vivo | E-poster | HIV-associated viruses, co-infections and co-morbidities |
| LBEPA06 | Epigenetic associations with APOL1 nephropathy and kidney function in individuals of African ancestry with HIV | E-poster | HIV-associated viruses, co-infections and co-morbidities |
| LBPEA02 | A rhesus macaque model of HIV/HBV co-infection | Poster exhibition | HIV-associated viruses, co-infections and co-morbidities |
| EPA0029 | Early initiation of anti-retroviral therapy restores some but not all perturbations of natural killer cell functions and phenotypes in early HIV-1 infected men who have sex with men | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0030 | Mitochondrial HSP60 ensures optimal energy-dependent immunity in antiviral T-cells | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0031 | Genetic signatures of HIV-infected CD4+ T cells that survive interactions with NK cells | E-poster | Host immune responses, vaccines and immunotherapies |